levodopa has been researched along with Optic Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fish, M; Hack, M; Majounie, E; Morris, HR; Newsway, V; Rohrer, JD; Warren, JD; Williams, N | 1 |
| Wakakura, M | 1 |
1 review(s) available for levodopa and Optic Nerve Diseases
| Article | Year |
|---|---|
[Experimental approaches to prophylactic neuroprotective treatment for retinal and optic nerve disorders].
Topics: Animals; Apoptosis; Cells, Cultured; Dopamine Agents; Humans; Levodopa; Necrosis; Neuroprotective Agents; Optic Nerve Diseases; Rabbits; Retinal Diseases | 2001 |
1 other study(ies) available for levodopa and Optic Nerve Diseases
| Article | Year |
|---|---|
Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.
Topics: Arginine; Behavioral Symptoms; DNA Mutational Analysis; Dopamine Agents; Dynactin Complex; Glycine; Humans; Levodopa; Male; Microtubule-Associated Proteins; Middle Aged; Neuropsychological Tests; Optic Nerve Diseases; Parkinsonian Disorders; Respiratory Insufficiency | 2010 |